WASHINGTON, DC - The PTCB Board of Governors has selected Colonel (ret) Everett McAllister, USAF, as the organization's new Executive Director and Chief Executive Officer. Colonel (ret) McAllister will join PTCB on March 5, 2012, succeeding Interim Executive Director, William Schimmel, who is returning to his role as Associate Executive Director.
Colonel (ret) McAllister has 27 years of health care leadership experience. Before joining PTCB, he was the Deputy Director of the Pharmaceutical Operations Directorate, TRICARE Management Activity, within the Office of the Assistant Secretary of Defense in Washington, DC. In this role, he served as the senior Department of Defense's (DoD) military pharmacist and policy advisor, responsible for managing the complex, multi-venued $7.6 billion pharmacy program, impacting over 9.6 million DoD beneficiaries worldwide. Prior, he served as the Pharmacy Consultant to the Air Force Surgeon General and the Associate Corps Chief for Pharmacy in the 11th Biomedical Science Corps.
"Colonel McAllister is a seasoned leader who brings not only impressive pharmacy experience, but also a distinct vision to PTCB,” said Thomas Menighan, PTCB Board of Governors Chair. “The Board's decision reaffirms PTCB's commitment to developing a qualified pharmacy technician workforce that is prepared to support pharmacists in advancing patient safety."
Col (ret) McAllister is a decorated service veteran. McAllister earned his Bachelor of Pharmacy from the University of South Carolina and a Masters of Public Administration from Auburn University. He entered the Air Force directly out of pharmacy school, where he participated in the school's Reserve Officer Training Commission program. During his military career he served in a variety of roles, directing pharmacies, clinical research, and pharmacy training programs.
"I have a unique appreciation of the services pharmacy technicians provide to the health care team," said McAllister. “Technicians are the backbone of the military health care system and I look forward to transitioning this understanding to the broader practice of pharmacy."